Publications and communications of Nadia WITHOFS

Jerusalem, G., & Withofs, N. (2009). Nuclear medicine imaging. In H.-J. Schmoll, L. Van't Veer, J. Vermorken, ... D. Schrijvers (Eds.), ESMO Handbook of Cancer Diagnosis and Treatment Evaluation (pp. 29-36). Informa Healthcare.

Rizzoli, E., Bahri, M. A., Dammicco, S., Degueldre, C., Tutunaru, A.-C., Garigliany, M.-M., Gérardy, M., Bolen, G., Withofs, N., Gendron, T., & Clercx, C. (15 January 2026). Evaluation of [18F]FAPI-74 PET/CT in healthy dogs and in West Highland white terriers with canine idiopathic pulmonary fibrosis: a pilot study. Veterinary Journal, 315, 106565. doi:10.1016/j.tvjl.2026.106565

Aziz, R., Muller, F. M., Withofs, N., Maebe, J., Dadgar, M., Vervenne, B., D'Asseler, Y., Vanhove, C., & Vandenberghe, S. (27 November 2025). Motion study on upright patient positioning in walk-through PET: evaluation in a clinical setting. EJNMMI Physics, 12 (1), 98. doi:10.1186/s40658-025-00815-7

Kleiburg, F., Dirix, P., Fonteyne, V., Bral, S., De Troyer, B., Sautois, B., Lamande, M., Liefhooghe, N., Grisay, G., Meersschout, S., Vandermeulen, A., Jullian, N., Staelens, L., Poelaert, F., Strijbos, M., Verschueren, J., Goffin, K., Withofs, N., & Ost, P. (2025). Stage Migration on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Comparison to Conventional Imaging in Patients with High-risk Prostate Cancer Referred for Radiation Therapy: Results from the Phase 2/3 THUNDER Trial. European Urology Oncology. doi:10.1016/j.euo.2025.08.005

Denis, C., Cousin, F., De Laere, B., Vanwelkenhuyzen, J., Hustinx, R., Sautois, B.* , & Withofs, N.*. (02 September 2025). Assessing Interlesional Tumor Response and Patient Outcomes with Sequential PSMA PET/CT in Metastatic Castration-Resistant Prostate Cancer. Journal of Nuclear Medicine, 66 (9), 1385 - 1391. doi:10.2967/jnumed.125.269729

Grandjean, F., Withofs, N., Detrembleur, N., GERARD, L., Lamborelle, P., VALKENBORGH, C., Dardenne, N., & Cousin, F. (02 April 2025). Incidence and features of pulmonary track nodules after CT-guided lung biopsy with track sealing using gelatin sponge slurry. BMC Medical Imaging, 25 (1), 107. doi:10.1186/s12880-025-01644-x

Steenhout, C., Deprez, L., Hustinx, R., & Withofs, N. (January 2025). Brain Tumor Assessment: Integrating PET/Computed Tomography and MR Imaging Modalities. PET Clinics, 20 (1), 165 - 174. doi:10.1016/j.cpet.2024.09.003

Stoffels, M., Cousin, F., Lamande, M., Denis, C., Waltregny, D., Hustinx, R., Sautois, B., & Withofs, N. (2024). Characterization of exclusive rib lesions detected by [68Ga]Ga-PSMA-11 PET/CT. Nuclear Medicine Communications. doi:10.1097/MNM.0000000000001919

Withofs, N., Bonnet, C., & Hustinx, R. (October 2024). 2-deoxy-2-[18F]FDG PET Imaging for Therapy Assessment in Hodgkin's and Non-Hodgkin Lymphomas. PET Clinics, 19 (4), 447 - 462. doi:10.1016/j.cpet.2024.05.001

Nanni, C., Deroose, C. M., Balogova, S., Lapa, C., Withofs, N., Subesinghe, M., Jamet, B., Zamagni, E., Ippolito, D., Delforge, M., & Kraeber-Bodéré, F. (2024). EANM guidelines on the use of [18F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-024-06858-9

MARCHIORI, S., Cousin, F., Papadopoulos, I., Bernard, C., THYS, M., DE PRIJCK, B., Pirotte, M., Donneau, A.-F., Hustinx, R., Caers, J., & Withofs, N. (28 May 2024). Prognostic value of visual IMPeTUs criteria and metabolic tumor burden at baseline [18F]FDG PET/CT in patients with newly diagnosed multiple myeloma. EJNMMI Research, 14 (1), 51. doi:10.1186/s13550-024-01113-6

Bocuzzi, V., Bridoux, J., PIROTTE, M., Withofs, N., Hustinx, R., D'Huyvetter, M., Caers, J., & Marcion, G. (2024). Correction to: CD38 as theranostic target in oncology (Journal of Translational Medicine, (2024), 22, 1, (998), 10.1186/s12967-024-05768-6). Journal of Translational Medicine, 22 (1), 1113. doi:10.1186/s12967-024-05959-1

LUCIA, F., Withofs, N., Lovinfosse, P., & Hustinx, R. (2024). TEP/TDM en radiothérapie : indications et perspectives. Revue Médicale de Liège.

Vandenberghe, S., Muller, F. M., Withofs, N., Dadgar, M., Maebe, J., Vervenne, B., Akl, M. A., Xue, S., Shi, K., Sportelli, G., Belcari, N., Hustinx, R., Vanhove, C., & Karp, J. S. (2023). Walk-through flat panel total-body PET: a patient-centered design for high throughput imaging at lower cost using DOI-capable high-resolution monolithic detectors. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06341-x

Nanni, C., Kobe, C., Baeßler, B., Baues, C., Boellaard, R., Borchmann, P., Buck, A., Buvat, I., Chapuy, B., Cheson, B. D., Chrzan, R., Cottereau, A.-S., Dührsen, U., Eikenes, L., Hutchings, M., Jurczak, W., Kraeber-Bodéré, F., Lopci, E., Luminari, S., ... Kunikowska, J. (May 2023). European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours. The Lancet Haematology, 10 (5), 367 - e381. doi:10.1016/S2352-3026(23)00030-3

WITHOFS, N., Kumar, R., Alavi, A., & HUSTINX, R. (July 2022). Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors: It Is Time to Rectify the Ongoing Misconceptions. PET Clinics, 17 (3), 327-342. doi:10.1016/j.cpet.2022.03.004

LOVINFOSSE, P., Ferreira, M., WITHOFS, N., JADOUL, A., Derwael, C., Frix, A.-N., GUIOT, J., BERNARD, C., Diep, A. N., Donneau, A.-F., LEJEUNE, M., BONNET, C., Vos, W., Meyer, P., & HUSTINX, R. (19 May 2022). Distinction of lymphoma from sarcoidosis at FDG PET/CT - evaluation of radiomic-feature guided machine learning versus human reader performance. Journal of Nuclear Medicine, 63, 1933-1940. doi:10.2967/jnumed.121.263598

Denis, C., COUSIN, F., De Laere, B., HUSTINX, R., SAUTOIS, B.* , & WITHOFS, N.*. (21 April 2022). Using, 68Ga-PSMA-11 PET/CT for therapy response assessment in patients with metastatic castration-resistant prostate cancer: an application of EAU/EANM recommendations in clinical practice. Journal of Nuclear Medicine, 63 (12), 1815-1821. doi:10.2967/jnumed.121.263611

Lamaye, C., Bastin, C., BERNARD, C., WITHOFS, N., HUSTINX, R., & SALMON, E. (April 2022). Analyse comparative de la distribution cérébrale du [18F]FDG dans une population de patients souffrant de maladie d’Alzheimer présentant ou non des antécédents familiaux de démence. Revue Médicale de Liège, 77 (4), 224-230.

Caers, J., Duray, E., Vrancken, L., Marcion, G., Bocuzzi, V., De Veirman, K., Krasniqi, A., Lejeune, M., Withofs, N., Devoogdt, N., Dumoulin, M., Karlström, A. E., & D'Huyvetter, M. (2022). Radiotheranostic Agents in Hematological Malignancies. Frontiers in Immunology, 13, 911080. doi:10.3389/fimmu.2022.911080

Mina, M., JACQUERIE, P., DUQUENNE, J. B., LAVIGNE, J.-P., BOULANGER, Y.-G., BISOGNI, C., Derwael, C., WITHOFS, N., MALAISE, M., & MALAISE, O. (2022). Périostite bilatérale et polyarthrite : à propos d'un cas d'ostéoarthropathie hypertrophique pneumique. Revue Médicale de Liège.

Denis, C., Sakalihasan, S., FRERES, P., WITHOFS, N., & SAUTOIS, B. (2021). Cemiplimab for cisplatin resistant metastatic penile cancer. Case Reports in Oncology, 14, 972-976. doi:10.1159/000517008

CHARLIER, E.* , DEROYER, C.* , NEUVILLE, S., Plener, Z., MALAISE, O., Ciregia, F., Gillet, P., Reuter, G., Salvé, M., Withofs, N., Hustinx, R., de Seny, D.* , & Malaise, M.*. (2020). Toward diagnostic relevance of the α(V)β(5), α(V)β(3), and α(V)β(6) integrins in OA: expression within human cartilage and spinal osteophytes. Bone Research, 8, 35. doi:10.1038/s41413-020-00110-4

Derwael, C., Lavergne, O., LOVINFOSSE, P., Nechifor, V., Salvé, M., Waltregny, D., Hustinx, R., & WITHOFS, N. (2020). Interobserver agreement of [(68)Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer. EJNMMI Research, 10 (1), 15. doi:10.1186/s13550-020-0596-4

WITHOFS, N., Beguin, Y., COUSIN, F., Tancredi, T., SIMONI, P., Alvarez-Miezentseva, V., DE PRIJCK, B., HAFRAOUI, K., Bonnet, C., Baron, F., Hustinx, R., & Caers, J. (2019). Dual-tracer PET/CT scan after injection of combined [ 18 F]NaF and [ 18 F]FDG outperforms MRI in the detection of myeloma lesions. Hematological Oncology, 37, 193-201. doi:10.1002/hon.2600

Heusschen, R., Muller, J., Duray, E., WITHOFS, N., Bolomsky, A., Baron, F., Beguin, Y., Menu, E., Ludwig, H., & Caers, J. (2018). Molecular mechanisms, current management and next generation therapy in myeloma bone disease. Leukemia and Lymphoma, 59, 14-28. doi:10.1080/10428194.2017.1323272

MARCHETTA, S., WITHOFS, N., ERBA, P. A., HABIB, G., HUSTINX, R., & LANCELLOTTI, P. (August 2017). RADIONUCLIDE IMAGING OF INFECTIVE ENDOCARDITIS: state of art and future perspective. Current Cardiovascular Imaging Reports, 10 (27). doi:10.1007/s12410-017-9425-1

Deleixhe, B., FRIPPIAT, F., Léonard, P., WITHOFS, N., MEEX, C., Pierard, L., & Moutschen, M. (2017). Endocardite à aggregatibacter aphrophilus sur prothèses valvulaires. Revue Médicale de Liège, 72 (12), 522-528.

Heusschen, R., Muller, J., WITHOFS, N., BARON, F., BEGUIN, Y., & CAERS, J. (2017). Multiple myeloma bone disease: from mechanisms to next generation therapy. Belgian Journal of Hematology, 8, 66-74.

Hillengass, J., Moulopoulos, L. A., Delorme, S., Koutoulidis, V., Mosebach, J., Hielscher, T., Drake, M., Rajkumar, S. V., Oestergaard, B., Abildgaard, N., Hinge, M., Plesner, T., Suehara, Y., Matsue, K., Waage, A., Goldschmidt, H., Dimopoulos, M. A., Lentzsch, S., Durie, B., ... CAERS, J. (2017). Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group. Blood Cancer Journal, 7 (8), 599. doi:10.1038/bcj.2017.78

WITHOFS, N., COUSIN, F., DE PRIJCK, B., Bonnet, C., Hustinx, R., Gambhir, S. S., Beguin, Y., & Caers, J. (2017). A First Report on [(18)F]FPRGD2 PET/CT Imaging in Multiple Myeloma. Contrast Media and Molecular Imaging, 2017, 6162845. doi:10.1155/2017/6162845

PAQUES, F., HAMOIR, E., LOVINFOSSE, P., HUSTINX, R., & WITHOFS, N. (2016). A case of added value of 123I-mIBG SPECT/CT imaging in the diagnosis of a pheochromocytoma extending into the left adrenal vein. Acta Chirurgica Belgica. doi:10.1080/00015458.2016.1240917

WITHOFS, N., & HUSTINX, R. (19 February 2016). Integrin αvβ3 and RGD-based radiopharmaceuticals. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 40 (2016), 41-54. doi:10.1016/j.mednuc.2015.12.002

Barrington, S. F., Fosse, P., WITHOFS, N., Itti, E., Hustinx, R., Couturier, O.-F., & Meignan, M. (2016). Recommendations to stage and assess the response to therapy of lymphomas with [18F]FDG-PET-CT. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 40 (1), 55 - 64. doi:10.1016/j.mednuc.2015.12.004

NCHIMI LONGANG, A., Courtois, A., EL HACHEMI, M., Touat, Z., Drion, P., WITHOFS, N., Warnock, G., Bahri, M. A., Dogné, J.-M., CHERAMY-BIEN, J.-P., SCHOYSMAN, L., Joskin, J., Michel, J.-B., Defraigne, J.-O., Plenevaux, A., & SAKALIHASAN, N. (2016). Multimodality imaging assessment of the deleterious role of the intraluminal thrombus on the growth of abdominal aortic aneurysm in a rat model. European Radiology, 26, 2378-2386. doi:10.1007/s00330-015-4010-y

WITHOFS, N., Martinive, P., VANDERICK, J., BLETARD, N., SCAGNOL, I., Mievis, F., Giacomelli, F., Coucke, P., Delvenne, P., Cataldo, D., Gambhir, S. S., & HUSTINX, R. (2016). [18F]FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-015-3219-y

WITHOFS, N., NANNI, C., SIMONI, P., FANTI, S., BEGUIN, Y., & CAERS, J. (20 March 2015). Imaging myeloma and related monoclonal plasma cell disorders using MRI, low dose whole-body CT and FDG PET/CT. Clinical and Translational Imaging, 3, 95-109. doi:10.1007/s40336-015-0119-x

WITHOFS, N., SIGNOLLE, N., SOMJA, J., LOVINFOSSE, P., MUTIJIMA NZARAMBA, E., Mievis, F., Giacomelli, F., WALTREGNY, D., CATALDO, D., GAMBHIR, S. S., & HUSTINX, R. (2015). 18F-FPRGD2 PET/CT imaging of integrin αvβ3 in renal carcinomas: Correlation with histopathology. Journal of Nuclear Medicine. doi:10.2967/jnumed.114.149021

WITHOFS, N., CHARLIER, E., Simoni, P., Alvarez-Miezentseva, V., Mievis, F., Giacomelli, F., Mella, C., Gambhir, S. S., Malaise, O., DE SENY, D., MALAISE, M., & HUSTINX, R. (2015). (18)F-FPRGD2 PET/CT imaging of musculoskeletal disorders. Annals of Nuclear Medicine, 29 (10), 839-47. doi:10.1007/s12149-015-1011-5

CAERS, J., WITHOFS, N., Hillengass, J., SIMONI, P., Zamagni, E., HUSTINX, R., & BEGUIN, Y. (April 2014). The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow-up of multiple myeloma. Haematologica, 99 (4), 629-37. doi:10.3324/haematol.2013.091918

LALLEMAND, F., LAKOSI, F., HUSTINX, R., WITHOFS, N., MEUNIER, P., TSHIBANDA, L., JODOGNE, S., COUCKE, P., & MARTINIVE, P. (2014). Utilisation de l'imagerie fonctionnelle en radiothérapie. Revue Médicale de Liège, 69 (Supp 1), 20-28.

SCHENA, A., Ansseau, M., TRIFFAUX, J.-M., Salmon, E., WITHOFS, N., & Scantamburlo, G. (2014). Le cas clinique du mois : Pseudo-démence dépressive. Revue Médicale de Liège, 69 (2), 64-67.

WITHOFS, N., BERNARD, C., VAN DER REST, C., MARTINIVE, P., HATT, M., JODOGNE, S., VISVIKIS, D., LEE, J. A., COUCKE, P., & HUSTINX, R. (2014). FDG PET/CT for rectal carcinoma radiotherapy treatment planning : Comparison of functional volume delineation algorithms and clinical challenges. Journal of Applied Clinical Medical Physics, 15 (5), 216-228. doi:10.1120/jacmp.v15i5.4696

WITHOFS, N., & HUSTINX, R. (2014). Imagerie de l'intégrine αvβ3 par PET/CT au 18F-FPRGD2. Revue Médicale de Liège, 69 (Synthèse 2014), 36-40.

SIMONI, P., STULKO, J., BEN MUSTAPHA, S., SCHOYSMAN, L., BIANCHI, E., WITHOFS, N., RACARU, T., CAERS, J., & ALVAREZ MIEZENTSEVA, V. (2013). Bone mass of the calvarium. Skeletal Radiology, 42, 1185-1187. doi:10.1007/s00256-012-1547-6

Govaerts, L., WITHOFS, N., DURIEUX, R., Spote, V., & Hustinx, R. (2012). Acute intramural haematoma of the ascending aorta. European Journal of Nuclear Medicine and Molecular Imaging, 39 (8), 1368-9. doi:10.1007/s00259-012-2130-z

Tran, P. T., Shroff, E. H., Burns, T. F., Thiyagarajan, S., Das, S. T., Zabuawala, T., Chen, J., Cho, Y.-J., Luong, R., Tamayo, P., Salih, T., Aziz, K., Adam, S. J., Vicent, S., Nielsen, C. H., WITHOFS, N., Sweet-Cordero, A., Gambhir, S. S., Rudin, C. M., & Felsher, D. W. (2012). Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis. PLoS Genetics, 8 (5), 1002650. doi:10.1371/journal.pgen.1002650

WITHOFS, N., COLLIGNON, J., & HUSTINX, R. (2011). Imagerie des métastases osseuses du cancer du sein. Revue Médicale de Liège, 66 (5-6), 291-298.

WITHOFS, N., COLLIGNON, J., RORIVE, A., JERUSALEM, G., & HUSTINX, R. (2011). Hétérogénéité des métastases osseuses du cancer du sein : cas clinique illustrant l'intérêt de combiner différentes techniques d'imagerie. Revue Médicale de Liège, 66 (5-6), 288-290.

Withofs, N., Grayet, B., Tancredi, T., Rorive, A., Mella, C., Giacomelli, F., Mievis, F., Aerts, J., Waltregny, D., Jerusalem, G., & Hustinx, R. (2011). 18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers. Nuclear Medicine Communications, 32 (3), 168-176. doi:10.1097/MNM.0b013e3283412ef5

COUCKE, P., WITHOFS, N., JANSEN, N., JANVARY, Z. L., & HUSTINX, R. (2010). Vers une radiothérapie chirurgicale :nécessité d’une radiothérapie guidée par l’imagerie. Revue Médicale de Liège, 65 (supp 1), 17-22.

Duysinx, B., Corhay, J.-L., Larock, M.-P., Withofs, N., Bury, T., Hustinx, R., & Louis, R. (2010). Contribution of positron emission tomography in pleural disease. Revue des Maladies Respiratoires, 27 (8), 47-53. doi:10.1016/j.rmr.2009.12.003

Nielsen, C. H., Kimura, R. H., WITHOFS, N., Tran, P. T., Miao, Z., Cochran, J. R., Cheng, Z., Felsher, D., Kjaer, A., Willmann, J. K., & Gambhir, S. S. (2010). PET imaging of tumor neovascularization in a transgenic mouse model with a novel 64Cu-DOTA-knottin peptide. Cancer Research, 70 (22), 9022-30. doi:10.1158/0008-5472.CAN-10-1338

Duysinx, B., Corhay, J.-L., Larock, M.-P., Withofs, N., Bury, T., Hustinx, R., & Louis, R. (2008). Apport de l'imagerie par tomographie a emission de positons dans la pathologie pleurale. Interet de la TEP en pathologie pleurale. Revue des Maladies Respiratoires, 25 (2), 129-38. doi:10.1016/S0761-8425(08)71511-0

Rutten, I., Cabay, J.-E., Withofs, N., Lemaire, C., Aerts, J., Baart, V., & Hustinx, R. (May 2007). PET/CT of skull base meningiomas using 2-F-18-fluoro-L-tyrosine: Initial report. Journal of Nuclear Medicine, 48 (5), 720-725. doi:10.2967/jnumed.106.038216

Jerusalem, G., Withofs, N., Rorive, A., & Hustinx, R. (2007). Tomographie a emission de positons: un premier bilan. Revue du Praticien, 57 (17), 1864-70.

Massin, M., Withofs, N., Maeyns, K., Ravet, F., & Gérard, P. (November 2001). Normal ranges for the variability in heart rate in young infants while sleeping. Cardiology in the Young, 11 (6), 619-625. doi:10.1017/S104795110100097X

Massin, M. M., Withofs, N., Maeyns, K., & Ravet, F. (2001). The Influence of Fetal and Postnatal Growth on Heart Rate Variability in Young Infants. Cardiology, 95 (2), 80-3. doi:10.1159/000047350

Massin, M. M., Maeyns, K., Withofs, N., Ravet, F., & Gérard, P. (August 2000). Circadian Rhythm of Heart Rate and Heart Rate Variability. Archives of Disease in Childhood, 83 (2), 179-82. doi:10.1136/adc.83.2.179

Massin, M. M., Maeyns, K., Withofs, N., & Gérard, P. (2000). Dependency of Premature Ventricular Contractions on Heart Rate and Circadian Rhythms During Childhood. Cardiology, 93 (1-2), 70-3. doi:10.1159/000007004

Withofs, N. (21 September 2023). LES RADIOTRACEURS AUTRES QUE LE PSMA-LIGAND POUR L’IMAGERIE TEP DU CANCER DE PROSTATE. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 47 (5), 281-290. doi:10.1016/j.mednuc.2023.07.008

Massin, M., Withofs, N., & Ravet, F. (April 2002). Heart rate variability in infants with obstructive sleep apnea. Archives de Pédiatrie, 9 (4), 444-445. doi:10.1016/S0929-693X(01)00808-9

WITHOFS, N., ALVAREZ MIEZENTSEVA, V., SIMONI, P., Luxen, A., GAMBHIR, S., & HUSTINX, R. (2013). Imaging osteoarthritis using (18F)FPRGD2 PET/CT : observation and potential application. Journal of Nuclear Medicine, 54 (SUPPL), 250.

WITHOFS, N., MARTINIVE, P., SCAGNOL, I., THONON, D., Giacomelli, F., Mievis, F., COUCKE, P., CATALDO, D., Gambhir, S., & HUSTINX, R. (2012). Preliminary results of (18F)FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma. Journal of Nuclear Medicine, 53 (SUPPL), 1703.

WITHOFS, N., SIGNOLLE, N., NZARAMBA, E., THONON, D., LEONARD, M., AERTS, J., WALTREGNY, D., CATALDO, D., GAMBHIR, S., & HUSTINX, R. (2012). (18F)FPRGD2 PET/CT imaging of integrin αvβ3 in renal carcinomas : correlation with histopathology. Journal of Nuclear Medicine, 53 (SUPPL), 1647.

WITHOFS, N., Bernard, C., VAN DER REST, C., MARTINIVE, P., HATT, M., Dimitris, V., COUCKE, P., & HUSTINX, R. (2011). FDG PET/CT for radiotherapy treatment planning. Comparison of functional volume delineation algorithms. Journal of Nuclear Medicine.

WITHOFS, N., GRAYET, B., Tancredi, T., RORIVE, A., BECKERS, C., JERUSALEM, G., & HUSTINX, R. (2008). PET/CT for assessing bone involvement in prostate and breast cancer. Journal of Nuclear Medicine, 49 (SUPPL), 21.

MEDART, L., WITHOFS, N., HUSTINX, R., & DONDELINGER, R. (2007). Gossypiboma at PET-CT. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.

MEDART, L., WITHOFS, N., HUSTINX, R., & DONDELINGER, R. (2007). Another etiology for inflammatory syndrome of unknown origin. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.

NAMUR, G., VAN DAMME, H., BECKERS, C., MEDART, M., WITHOFS, N., & HUSTINX, R. (2007). FDG PET/CT for diagnostic arterial prosthetic graft infection : preliminary report. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.

RUTTEN, I., CABAY, J.-E., WITHOFS, N., LEMAIRE, C., AERTS, J., BAART, V., & HUSTINX, R. (2007). PET/CT imaging of skull base meningiomas using 1-18F-fluoro-L-tyrosine; initial report. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.

Withofs, N., Salmon, E., Hallet, C., Desfontaines, P., Laureys, S., Moonen, G., & Hustinx, R. (May 2007). Effect of dementia severity and age on posterior cingulate cortex metabolism in Alzheimer's disease. Journal of Neurology, 254 (Suppl. 3), 146.

WITHOFS, N., SALMON, E., LAUREYS, S., DESFONTAINES, P., MOONEN, G., & HUSTINX, R. (2007). Voxel-based analysis of posterior cingulated cortex metabolism in Alzheimer’s disease : effect of dementia severity and age. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.

Rutten, I., Cabay, J.-E., Withofs, N., Lemaire, C., Aerts, J., Baart, V., & HUSTINX, R. (2007). PET/CT imaging of skull base meningiomas using 2-18F-fluoro-L-tyrosine : Initial report. Journal of Nuclear Medicine, 48 (SUPPL), 11.

WITHOFS, N., SALMON, E., LAUREYS, S., DESFONTAINES, P., & HUSTINX, R. (2007). Voxel-based analysis of dementia severity versus age on cerebral metabolic dysfunction in Alzheimer’s disease. Journal of Nuclear Medicine, 48 (SUPPL), 172.

Rizzoli, E., Bahri, M. A., Dammicco, S., Degueldre, C., Legrand, M., Tutunaru, A.-C., Bolen, G., Withofs, N., Gendron, T., & Clercx, C. (19 December 2024). [18F]FAPI-74 PET/CT in dogs with idiopathic pulmonary fibrosis [Paper presentation]. 11th FARAH Day, Liège, Belgium.

Rizzoli, E., Bahri, M. A., Dammicco, S., Degueldre, C., Tutunaru, A.-C., Legrand, M., Bolen, G., Withofs, N., Gendron, T., & Clercx, C. (19 November 2024). [18F]FAPI-74 PET/CT in dogs with idiopathic pulmonary fibrosis [Paper presentation]. Veterinary Comparative Respiratory Society Symposium, Levi, Finland.

Somja, J., Collins, P., Lampertz, S., Withofs, N., Bisig, B., & de Leval, L. (22 September 2022). Early phase of Angioimmunoblastic T-cell Lymphoma mimicking Marginal Zone Lymphoma [Paper presentation]. 21th Meeting of the European Association for Haematopathology, Florence, Italy.

Ehx, G., Fransolet, G., de Leval, L., Stéphanie D'Hondt, Sophie Lucas, Guillaume Becker, Withofs, N., Hannon, M., Delens, L., Drion, P., Beguin, Y., Stéphanie Humblet-Baron, & Baron, F. (March 2017). Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects [Paper presentation]. 43rd Annual Meeting of the EBMT, Marseille, France.